Cargando…
B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012126/ http://dx.doi.org/10.1097/01.HS9.0000829556.56345.01 |
_version_ | 1784687736863588352 |
---|---|
author | Rodriguez-Otero, P Dholaria, B Askari, E Reece, D van de Donk, N Chari, A Goldschmidt, H Krishnan, A Martin, T Mateos, M Morillo, D Rodriguez, C Rosinol, L San-Miguel, J Balari, A Wäsch, R Weisel, K Verona, R Lin, S Prior, T Wade, M Weiss, B Goldberg, J Oriol, A Hari, P |
author_facet | Rodriguez-Otero, P Dholaria, B Askari, E Reece, D van de Donk, N Chari, A Goldschmidt, H Krishnan, A Martin, T Mateos, M Morillo, D Rodriguez, C Rosinol, L San-Miguel, J Balari, A Wäsch, R Weisel, K Verona, R Lin, S Prior, T Wade, M Weiss, B Goldberg, J Oriol, A Hari, P |
author_sort | Rodriguez-Otero, P |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9012126 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-90121262022-04-18 B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY Rodriguez-Otero, P Dholaria, B Askari, E Reece, D van de Donk, N Chari, A Goldschmidt, H Krishnan, A Martin, T Mateos, M Morillo, D Rodriguez, C Rosinol, L San-Miguel, J Balari, A Wäsch, R Weisel, K Verona, R Lin, S Prior, T Wade, M Weiss, B Goldberg, J Oriol, A Hari, P Hemasphere Best Abstracts - Oral Presentations Lippincott Williams & Wilkins 2022-04-05 /pmc/articles/PMC9012126/ http://dx.doi.org/10.1097/01.HS9.0000829556.56345.01 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Best Abstracts - Oral Presentations Rodriguez-Otero, P Dholaria, B Askari, E Reece, D van de Donk, N Chari, A Goldschmidt, H Krishnan, A Martin, T Mateos, M Morillo, D Rodriguez, C Rosinol, L San-Miguel, J Balari, A Wäsch, R Weisel, K Verona, R Lin, S Prior, T Wade, M Weiss, B Goldberg, J Oriol, A Hari, P B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY |
title | B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY |
title_full | B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY |
title_fullStr | B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY |
title_full_unstemmed | B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY |
title_short | B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY |
title_sort | b04: combination of subcutaneous teclistamab with daratumumab in patients with relapsed/refractory multiple myeloma (rrmm): results from a phase 1b multicohort study |
topic | Best Abstracts - Oral Presentations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012126/ http://dx.doi.org/10.1097/01.HS9.0000829556.56345.01 |
work_keys_str_mv | AT rodriguezoterop b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT dholariab b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT askarie b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT reeced b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT vandedonkn b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT charia b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT goldschmidth b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT krishnana b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT martint b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT mateosm b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT morillod b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT rodriguezc b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT rosinoll b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT sanmiguelj b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT balaria b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT waschr b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT weiselk b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT veronar b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT lins b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT priort b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT wadem b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT weissb b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT goldbergj b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT oriola b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy AT harip b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy |